These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 21743968)

  • 1. Inhibin-α subunit in normal and malignant human cervical tissue and cervical cancer cell lines.
    Mylonas I; Dian D
    Oncol Rep; 2011 Oct; 26(4):887-91. PubMed ID: 21743968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunolabelling of the inhibin/activin-βC subunit in normal and malignant human uterine cervical tissue and cervical cancer cell lines.
    Blankenstein T; Jückstock J; Shabani N; Kunze S; Brüning A; Bergauer F; Mylonas I
    Oncol Rep; 2011 Jan; 25(1):147-52. PubMed ID: 21109970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibin-betaA and -betaB subunits in normal and malignant glandular epithelium of uterine cervix and HeLa cervical cancer cell line.
    Burges A; Shabani N; Brüning A; Mylonas I
    Arch Gynecol Obstet; 2011 Oct; 284(4):981-8. PubMed ID: 21082187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibin/activin-betaE subunit in normal and malignant human cervical tissue and cervical cancer cell lines.
    Bergauer F; Brüning A; Shabani N; Blankenstein T; Jückstock J; Dian D; Mylonas I
    J Mol Histol; 2009 Oct; 40(5-6):353-9. PubMed ID: 20033758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunolabeling of the inhibin-βA and -βB subunit in normal and malignant human cervical tissue and cervical cancer cell lines.
    Jückstock J; Brüning A; Blankenstein T; Kunze S; Shabani N; Bergauer F; Mylonas I
    Int J Gynecol Cancer; 2010 Oct; 20(7):1117-24. PubMed ID: 21475087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibin/activin-betaC and -betaE subunits in the Ishikawa human endometrial adenocarcinoma cell line.
    Kimmich T; Brüning A; Käufl SD; Makovitzky J; Kuhn C; Jeschke U; Friese K; Mylonas I
    Arch Gynecol Obstet; 2010 Aug; 282(2):185-91. PubMed ID: 20012305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of activin A in hyperplasia and adenocarcinoma of the human endometrium.
    Otani T; Minami S; Yamoto M; Umesaki N
    Gynecol Oncol; 2001 Oct; 83(1):31-8. PubMed ID: 11585411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immunohistochemical expression of the inhibin/activin subunits is up-regulated by interferon-beta1a in Ishikawa cell line.
    Hoeing A; Kuhn C; Shabani N; Schulze S; Gingelmaier A; Dian D; Jeschke U; Friese K; Mylonas I
    Anticancer Res; 2007; 27(4A):2005-10. PubMed ID: 17649813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the inhibin/activin subunits (-alpha, -betaA and -betaB) in normal and carcinogenic endometrial tissue: possible immunohistochemical differentiation markers.
    Worbs S; Shabani N; Mayr D; Gingelmaier A; Makrigiannakis A; Kuhn C; Jeschke U; Kupka MS; Friese K; Mylonas I
    Oncol Rep; 2007 Jan; 17(1):97-104. PubMed ID: 17143484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibin-α subunit expression in uterine endometrioid adenocarcinomas and endometrial cancer cell lines: a potential prognostic factor.
    Mylonas I
    Int J Mol Med; 2011 Mar; 27(3):309-18. PubMed ID: 21174065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of inhibins in the endometrial carcinoma cell line RL-95-2 after stimulation with cortisol and estradiol.
    Vogl J; Höing A; Schulze S; Kuhn C; Wiest I; Shabani N; Jeschke U; Mylonas I; Friese K
    Anticancer Res; 2007; 27(4A):1989-93. PubMed ID: 17649810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibin-alpha, -betaA and -betaB subunits in uterine non-endometrioid carcinomas: prognostic significance and clinical implications.
    Mylonas I
    Eur J Cancer; 2010 Sep; 46(13):2485-93. PubMed ID: 20599374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and secretion of inhibin and activin in normal and neoplastic uterine tissues. High levels of serum activin A in women with endometrial and cervical carcinoma.
    Petraglia F; Florio P; Luisi S; Gallo R; Gadducci A; Viganò P; Di Blasio AM; Genazzani AR; Vale W
    J Clin Endocrinol Metab; 1998 Apr; 83(4):1194-200. PubMed ID: 9543140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the inhibin/activin subunits alpha (alpha), beta-A (betaA) and beta-B (betaB) in benign human endometrial polyps and tamoxifen-associated polyps.
    Mylonas I; Makovitzky J; Fernow A; Richter DU; Jeschke U; Briese V; Gerber B; Friese K
    Arch Gynecol Obstet; 2005 Jun; 272(1):59-66. PubMed ID: 15309402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibin/activin subunits beta-A (-betaA) and beta-B (-betaB) are differentially localised in normal, hyperplastic and malignant human endometrial tissue.
    Mylonas I; Makovitzky J; Hoeing A; Richter DU; Vogl J; Schulze S; Jeschke U; Briese V; Friese K
    Acta Histochem; 2006; 108(1):1-11. PubMed ID: 16423381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of activin and inhibin subunits, receptors and binding proteins in human pheochromocytomas: a study based on mRNA analysis and immunohistochemistry.
    Hofland J; van Nederveen FH; Timmerman MA; Korpershoek E; de Herder WW; Lenders JW; Verhofstad AA; de Krijger RR; de Jong FH
    Clin Endocrinol (Oxf); 2007 Mar; 66(3):335-40. PubMed ID: 17302865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developmental changes in inhibin alpha and inhibin/activin betaA and betaB mRNA levels in the gonads during post-hatch prepubertal development of male and female chickens.
    Onagbesan OM; Safi M; Decuypere E; Bruggeman V
    Mol Reprod Dev; 2004 Jul; 68(3):319-26. PubMed ID: 15112325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibin-βA subunit immunolabeling as a prognostic factor in endometrioid adenocarcinomas: a matter of evaluation?
    Mylonas I
    Arch Gynecol Obstet; 2011 Aug; 284(2):467-76. PubMed ID: 20865419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of SKP2 and phospho-MAPK/ERK1/2 and decreased expression of p27 during tumor progression of cervical neoplasms.
    Chen TP; Chen CM; Chang HW; Wang JS; Chang WC; Hsu SI; Cho CL
    Gynecol Oncol; 2007 Mar; 104(3):516-23. PubMed ID: 17079005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocyte growth factor/scatter factor is implicated in the mode of stromal invasion of uterine squamous cervical cancer.
    Shimabukuro K; Ichinose S; Koike R; Kubota T; Yamaguchi M; Miyasaka M; Aso T
    Gynecol Oncol; 2001 Nov; 83(2):205-15. PubMed ID: 11606073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.